BarberCGoldWLFortinPR. Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol2011; 23: 358–365.
2.
GoldblattFChambersSRahmanA, et al.Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus2009; 18: 682–689.
3.
EcheverriANaranjo-EscobarJPosso-OsorioI, et al.Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS. Lupus2018; 27: 1130–1139.
4.
DürrUHNSudheendraUSRamamoorthyA. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta – Biomembr2006; 1758: 1408–1425.
5.
LarsenFFPetersenJA. Novel biomarkers for sepsis: a narrative review. Eur J Intern Med2017; 45: 46–50.
6.
PorteRDavoudianSAsgariF, et al.The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Front Immunol2019; 10: 794–794.
